Investigational new drug approval of DA-1241: what we know about GPR119 targeting for MASH therapy?

Autor: Al Smadi K; Department of Gastroenterology and Hepatology, University of California - Riverside School of Medicine, Rialto, CA, USA., Qureshi A; Department of Gastroenterology and Hepatology, University of California - Riverside School of Medicine, Rialto, CA, USA., Ashouri B; Department of Gastroenterology and Hepatology, University of California - Riverside School of Medicine, Rialto, CA, USA., Kayali Z; Department of Gastroenterology and Hepatology, University of California - Riverside School of Medicine, Rialto, CA, USA.

Publikováno v: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2024 Sep; Vol. 33 (9), pp. 877-880. Date of Electronic Publication: 2024 Aug 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Finally sofosbuvir: an oral anti-HCV drug with wide performance capability

Autor: Kayali Z, Schmidt WN

Publikováno v: Pharmacogenomics and Personalized Medicine, Vol 2014, Iss default, Pp 387-398 (2014)

Zeid Kayali,1 Warren N Schmidt2,3 1Division of Gastroenterology and Hepatology, University of Southern California, Los Angeles, CA, USA; 2Department of Internal Medicine and Research Service, Veterans Affairs Medical Center, Iowa City, IA, USA; 3Roy

Externí odkaz: https://doaj.org/article/d8c9984c441d4b68b19b194987985c3c

A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.

Autor: D'Haens G; Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Peyrin-Biroulet L; Inserm NGERE and Department of Gastroenterology, University Hospital of Nancy, Université de Lorraine, Vandoeuvre-les-Nancy, France., Marks DJB; GSK, Discovery Medicine, GSK Medicine Research Centre, Stevenage, UK., Lisi E; GSK, Biostatistics, GSK Medicines Research Centre, Stevenage, UK., Liefaard L; GSK, Clinical Pharmacology Modelling and Simulation, GSK Medicines Research Centre, Stevenage, UK., Beaton A; GSK, Clinical Sciences, Medicines Research Centre, London, UK., Srinivasan N; GSK, Immunology Research Unit, Stevenage, UK., Bouma G; GSK, Clinical Pharmacology and Experimental Medicine, GSK Medicines Research Centre, Stevenage, UK., Prasad N; GSK, Computational Biology, Genomic Sciences Group, Stevenage, UK., Cameron R; GSK, Clinical Sciences, GSK, London, UK., Kayali Z; ACE Endoscopy, Suite C Inland Empire Liver Foundation, Rialto, California, USA., Tarzi R; GSK, Clinical Sciences, Medicines Research Centre, Stevenage, UK., Hanauer S; Northwestern University Feinberg School of Medicine, Northwestern Medicine Digestive Health Center, Chicago, Illinois, USA., Sandborn WJ; Division of Gastroenterology, University of California, San Diego, La Jolla, California, USA.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Aug; Vol. 58 (3), pp. 283-296. Date of Electronic Publication: 2023 Jun 16.

Spider diagram and sustainability evaluation of UV-methods strategy for quantification of aspirin and sildenafil citrate in the presence of salicylic acid in their bulk and formulation.

Autor: Kayali Z; Department of Analytical and Food Chemistry, Faculty of Pharmacy, Aleppo University, Aleppo, Syria., Obaydo RH; Department of Analytical and Food Chemistry, Faculty of Pharmacy, Ebla Private University, Idlib, Syria., Alhaj Sakur A; Department of Analytical and Food Chemistry, Faculty of Pharmacy, Aleppo University, Aleppo, Syria.

Publikováno v: Heliyon [Heliyon] 2023 Apr 05; Vol. 9 (4), pp. e15260. Date of Electronic Publication: 2023 Apr 05 (Print Publication: 2023).